鶹ýӰ

Video

Bladder Cancer Video Pearls

More in Bladder Cancer Video Pearls

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

Patients with complete response can have long treatment-free interval, study suggests

Nov 15, 2024
image
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer

And nearly half of responders to enfortumab vedotin plus pembrolizumab remained in remission

Nov 08, 2024
image
Sequencing in Advanced Urothelial Carcinoma

Navigating second-line options

Nov 01, 2024
image

1.00 CME Credits
Improving Transitions of Care and Long-Term Outcomes for Patients With Spinal Muscular Atrophy (SMA)

0.50 CME Credits
Developing Patient-Centered Approaches to Optimize the Management of Bipolar I Disorder

2.00 CME Credits
Appropriate Healthcare Interventions in Elder, Child, and Intimate Partner Abuse

3.00 CME Credits
Pain Management and the 2022 CDC Guideline for Prescribing Opioids for Pain

1.00 CME Credits
Engaging Older Adults in Vaccine Education: A Toolkit for Healthcare Providers

0.50 CME Credits
Integrating Biomarkers and Guideline-Aligned Treatment Approaches Into Evidence-Based Care for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

1.00 CME Credits
Uncomplicated Urinary Tract Infections: Leveraging Real-World Insights to Improve Patient Care

0.25 CME Credits
Utilizing Biomarkers and Prognostic Factors to Identify Rheumatoid Arthritis Patients at Risk for Poor Outcomes